Department of Neurosurgery, University Hospital Salzburg, Paracelsus Medical University, Salzburg, Austria.
Department of Neurology, Paracelsus Medical University, Salzburg, Austria.
Acta Neurochir (Wien). 2021 May;163(5):1515-1524. doi: 10.1007/s00701-021-04746-x. Epub 2021 Feb 10.
In Europe, aneurysm treatment performed by dually trained neurosurgeons is extremely scarce. We provide outcome data for un-ruptured aneurysm patients treated at a European hybrid center to prove that hybrid neurosurgeons achieve clinical and angiographical results allowing to integrate hybrid neurosurgery into routine aneurysm treatment. This will not only help to maintain neurovascular microsurgical skills but will influence staff costs in related hospitals.
We retrospectively analyzed all consecutively treated un-ruptured aneurysm patients between 2000 and 2016. The decision-making took into account the pros and cons of both modalities and considered patient and aneurysm characteristics. Clinical outcome was assessed by the modified Rankin scale (mRS). Occlusion rates were stratified into grade I for 100%, grade II for 99-90%, and grade III for <90% occlusion. To account for the introduction of stents, two treatment periods (p1, 2000 to 2008; p2, 2009 to 2016) were defined.
The study population consisted of 274 patients (median age 55 years) harboring 338 un-ruptured aneurysms. Microsurgery (MS) was performed in 51.8% and endovascular therapy (EVT) in 43.1%; 5.1% required combined treatment. Overall, 93% showed a favorable clinical outcome (mRS 0-2), 94.3% after MS and 91.5% after EVT. Grade I aneurysm occlusion was achieved in 82.6% patients, 91.9% after MS and 72.9% after EVT. Procedure-related complications occurred after MS in 5.6% and after EVT in 4.4% patients. Mortality was recorded for five (1.8%) patients, one patient after MS and four after EVT. For the EVT cohort, significant improvement from p1 to p2 was seen with clinical outcomes (P=0.030, RR = 0.905, CI: 0.8351-0.9802) and occlusion rates (P=0.039, RR = 0.6790, CI: 0.499-0.923).
Hybrid neurosurgeons achieve qualified clinical and angiographic results. Dual training will allow to maintain neurovascular caseloads and preserve future aneurysm treatment within neurosurgery. Furthermore economic benefits could be observed in hospital management.
在欧洲,双重培训的神经外科医生进行的动脉瘤治疗极为罕见。我们提供了在欧洲杂交中心治疗的未破裂动脉瘤患者的结果数据,以证明杂交神经外科医生可以获得临床和血管造影结果,从而将杂交神经外科纳入常规动脉瘤治疗。这不仅有助于维持神经血管显微外科技能,而且还会影响相关医院的人员成本。
我们回顾性分析了 2000 年至 2016 年间连续治疗的所有未破裂的动脉瘤患者。决策考虑了两种方式的利弊,并考虑了患者和动脉瘤的特征。临床结果通过改良的 Rankin 量表(mRS)进行评估。闭塞率分为 100%为 I 级,99%-90%为 II 级,<90%为 III 级。为了考虑支架的引入,将治疗期定义为两个时期(p1,2000 年至 2008 年;p2,2009 年至 2016 年)。
研究人群包括 274 例(中位年龄 55 岁)患有 338 个未破裂的动脉瘤患者。其中显微手术(MS)治疗 51.8%,血管内治疗(EVT)治疗 43.1%;5.1%需要联合治疗。总体而言,93%的患者表现出良好的临床结果(mRS 0-2),MS 后为 94.3%,EVT 后为 91.5%。I 级动脉瘤闭塞率在 82.6%的患者中达到,MS 后为 91.9%,EVT 后为 72.9%。MS 后有 5.6%的患者出现与手术相关的并发症,EVT 后有 4.4%的患者出现与手术相关的并发症。5 例(1.8%)患者死亡,1 例死于 MS,4 例死于 EVT。对于 EVT 组,临床结果(P=0.030,RR=0.905,CI:0.8351-0.9802)和闭塞率(P=0.039,RR=0.6790,CI:0.499-0.923)均有显著改善。
杂交神经外科医生可以获得合格的临床和血管造影结果。双重培训将允许维持神经血管病例量,并在神经外科内保留未来的动脉瘤治疗。此外,医院管理中可以观察到经济效益。